<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="296248" id="root" date="1997-01-09" xml:lang="en">
<title>USA: Global Pharmaceutical, Genpharm in pact.</title>
<headline>Global Pharmaceutical, Genpharm in pact.</headline>
<dateline>PHILADELPHIA, Pa 1997-01-09</dateline>
<text>
<p>Global Pharmaceutical Corp said on Thursday it signed a technical collaboration agreement with Genpharm Inc, a subsidiary of Merck KGaA.</p>
<p>Under terms of the agreement, Genpharm would transfer files to Global Pharmaceuticals relating to the manufacture of several drugs in solid dosage form, Global said.  </p>
<p>Under the original agreement, Global was to manufacture and package a minimum of 30 percent of Genpharm's total U.S. Ranitidine production requirement.</p>
<p>Now, Global said it would have similar profit sharing terms, but Ranitidine would be manufactured directly by Genpharm. Global would continue to be responsible for packaging the product for the U.S. market.</p>
<p>The new deal freed up funds that would have been used to buy machines to make Ranitidine, Global said.</p>
<p>&quot;Furthermore, the new arrangement has the potential to trigger the future issuance of Global stock to Merck KGaA under an existing warrant agreement with Merck KGaA, providing additional profit incentives for both companies,&quot; Max Mendelsohn, Global president and chief executive officer said.</p>
<p>Merck KGaA is a five percent stockholder of Global.</p>
<p>Under terms of the warrant agreement, Merck KGaA could buy 40,000 shares of Global common stock for each $1 million in gross profit Global earned in connection with its sale of products obtained from Merck KGaA, it said.</p>
<p>((New York newsdesk 212-859-1610))</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-09"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-09"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C33">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-09"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-01-09"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-01-09"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-01-09"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="PHILADELPHIA, Pa"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
